Silver Book Fact

An experimental drug has been found to extend the lives of kidney patients by about 3.5 months–from 7 to just under 11. It has also been shown to delay tumor growth. Patients lived a median of 3.7 months before their tumors got worse–as opposed to 1.9 months.

Szabo L. New Weapons Do Battle with Kidney Cancer. USA Today. June 4 2006. http://www.usatoday.com/news/health/2006-06-04-kidney-cancer_x.htm?csp=34

Reference

Title
New Weapons Do Battle with Kidney Cancer
Publication
USA Today
Publication Date
June 4 2006
Authors
Szabo L
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • New cancer treatments account for large percent of life expectancy gains
     
  • Treating cancer patients with oral medicine versus intravenous chemotherapy results in a 2/3 reduction in hospital time and a greater than 50% reduction in costly medication side effects.  
  • A drug that can reduce the risk of breast cancer in high-risk women costs approximately $1,050 per year. The average cost per year for surgery or other invasive methods of…  
  • New Drug Increases Brain Cancer Survival Rate: Temozolomide is the first new drug in over 30 years to treat glioblastoma, a severe form of brain cancer  
  • Investments in cancer care generated $598 billion of additional value for cancer patients diagnosed between 1983 and 1999.